Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 201–300 of 1,001
Xiong, N., Yan-Jiao, Z. H. A. O., Dong, X., Zheng, J., & Sun, Y. P. (2017) · Small · doi:10.1002/smll.201601666 · Cited by 107
Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer
Malik, I., Шевцова, З. І., Bähr, M., & Kügler, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.014 · Cited by 116
“Aberrant cell death activation in the adult CNS is implicated in many neurodegenerative diseases, although it is still controversial which parts of the cell death cascades are actually activated in certain diseases and to what extent they finally contribute to neurodegeneration [21–23].”
BackgroundEpigenetics in neurodegeneration: A new layer of complexity
Marques, S., Oliveira, C. R., Pereira, C., & Outeiro, T. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.008 · Cited by 115
“The conformational change that results in the accumulation of misfolded proteins— amyloid-β (Aβ) and tau in AD and α-synuclein in PD— is associated with progressive dysfunction and death of cells in selected brain areas, determining clinical presentation (Soto, 2003).”
BackgroundNava-Mesa, M. O., Jiménez-DÃaz, L., Yajeya, J., & Navarro-Lopez, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 106
Howarth, J., Kelly, S., Keasey, M., Glover, C., Lee, Y.-B., Mitrophanous, K., Chapple, J., Gallo, J., Cheetham, M., & Uney, J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300163 · Cited by 107
Garcia, S. M., Casanueva, M. O., Silva, M. C., Amaral, M. D., & Morimoto, R. I. (2007) · Genes & Development · doi:10.1101/gad.1575307 · Cited by 105
Kinetic Stabilization of an Oligomeric Protein by a Single Ligand Binding Event
Wiseman, R. L., Johnson, S. M., Kelker, M. S., Foss, T. R., Wilson, I. A., & Kelly, J. W. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042929f · Cited by 104
The controversial protein-only hypothesis of prion propagation
Soto, C. A., & Castilla, J. (2004) · Nature Medicine · doi:10.1038/nm1069 · Cited by 128
Self-citationRussell, T. A., Ito, M., Ito, M., Yu, R. N., Martinson, F. A., Weiss, J. P., & Jameson, J. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18616 · Cited by 101
Rates of Decline in Alzheimer Disease Decrease with Age
Holland, D., Desikan, R. S., Dale, A. M., McEvoy, L. K., & Initiative, F. T. A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042325 · Cited by 99
“Pathologically, AD is characterized by the misfolding [7–9] and accumulation of amyloid-beta (Ab) and tau proteins in insoluble aggregates, leading to the formation of amyloid plaques and neurofibrillary tangles (NFTs) [10,11].”
BackgroundA striatal-enriched intronic GPCR modulates huntingtin levels and toxicity
Yao, Y., Cui, X., Al‐Ramahi, I., Sun, X., Li, B., Hou, J., DiFiglia, M., Palacino, J. J., Wu, Z., Ma, L., et al. (2015) · eLife · doi:10.7554/elife.05449 · Cited by 102
“Many similarities appear in these diseases, such as selective loss of neurons in certain brain regions and accumulation of aggregation-prone proteins (Soto, 2003).”
BackgroundAβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies
Rajasekhar, K., Narayanaswamy, N., Murugan, N. A., Viccaro, K., Lee, H.-G., Shah, K., & Govindaraju, T. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.06.030 · Cited by 97
Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating Neuroinflammation
Carregosa, D., Carecho, R., Figueira, I., & dos Santos, C. N. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02155 · Cited by 109
Seidel, K., Vinet, J., den Dunnen, W. F. A., Brunt, E. R., Meister, M., Boncoraglio, A., Zijlstra, M. P., Boddeke, H. W. G. M., Rüb, U., Kampinga, H. H., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01198.x · Cited by 98
Increased expression and processing of caspase‐12 after traumatic brain injury in rats
Larner, S. F., Hayes, R. L., McKinsey, D. M., Pike, B. R., & Wang, K. K. W. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02141.x · Cited by 100
“In addition, the disruption of ER homeostasis is considered a causal factor in pathologically-relevant apoptosis and has been implicated in several neurodegenerative disorders (Aridor and Balch 1999; Soto 2003).”
BackgroundAdvances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Spuch, C., Ortolano, S., & Navarro, C. (2012) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221112799219125 · Cited by 108
“Despite the important differences in clinical manifestation, neurodegenerative disorders share common features such as their appearance late in life, the extensive neuronal loss and synaptic abnormalities, and the presence of cerebral deposits of misfolded proteins aggregates [3].”
BackgroundProtein aggregation and ER stress
Ogen‐Shtern, N., David, T. B., & Lederkremer, G. Z. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.044 · Cited by 106
Aggregation of Disordered Proteins Associated with Neurodegeneration
Tsoi, P. S., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043380 · Cited by 115
“The four aforementioned proteins undergo misfolding from their native states to form β-sheet-rich structures ranging from small oligomers to large fibrillar aggregates in diseased brains [43,44].”
BackgroundDing, J., Lin, J. C., Mace, B. E., Herrmann, R., Sullivan, P. M., & Rickman, C. B. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.025 · Cited by 109
“Among the principal differences is the fact that classical amyloid diseases typically exhibit large amounts of amyloid fibrils (Soto 2003).”
Amyloid-beta and tau pathology following repetitive mild traumatic brain injury
Edwards, G., Moreno-Gonzalez, I., & Soto, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.123 · Cited by 96
Self-citationPlatt, G. W., Routledge, K. E., Homans, S. W., & Radford, S. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.092 · Cited by 112
“7).(54) Previously, short sequence stretches of proteins have been targeted by self-recognition peptidomimetic compounds that disrupt amyloid formation.”
BackgroundMatus, S., Lopez, E., Valenzuela, V., Nassif, M., & Hetz, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066672 · Cited by 98
“ALS is part of a large group of neurodegenerative diseases classified as protein conformational disorders that are characterized by the presence of abnormal protein aggregates in the form of inclusions or oligomers in affected neurons [44].”
BackgroundHierarchical chemical determination of amyloid polymorphs in neurodegenerative disease
Li, D., & Liu, C. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00708-z · Cited by 97
Hughes, M. M., Field, R. H., Perry, V. H., Murray, C. L., & Cunningham, C. (2010) · Glia · doi:10.1002/glia.21070 · Cited by 94
Damante, C. A., Ösz, K., Nagy, Z., Pappalardo, G., Grasso, G., Impellizzeri, G., Rizzarelli, E., & Sóvágó, I. (2008) · Inorganic Chemistry · doi:10.1021/ic8006052 · Cited by 100
Molecular Mapping of the Recognition Interface between the Islet Amyloid Polypeptide and Insulin
Gilead, S., Wolfenson, H., & Gazit, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602034 · Cited by 96
Beck, M. W., Derrick, J. S., Kerr, R. A., Oh, S. B., Cho, W. J., Lee, S. J. C., Ji, Y., Han, J., Tehrani, Z. A., Suh, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms13115 · Cited by 101
Extensive accumulation of misfolded protein aggregates during natural aging and senescence
Cuanalo-Contreras, K., Schulz, J., Mukherjee, A., Park, K.-W., Armijo, E., & Soto, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1090109 · Cited by 92
“Misfolding and aggregation leads to protein insolubilization, resistance to elimination by cellular clearance and the ability of the aggregates to bind to certain amyloid-binding dyes (e.g., Thioflavin; Soto and Pritzkow, 2018).”
BackgroundInfluentialSelf-citationA Mobile Precursor Determines Amyloid-β Peptide Fibril Formation at Interfaces
Shen, L., Adachi, T., Bout, D. V., & Zhu, X. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305398f · Cited by 101
Kavungal, D., Magalhães, P., Kumar, S. T., Rajasekhar, K., Lashuel, H. A., & Altug, H. (2023) · Science Advances · doi:10.1126/sciadv.adg9644 · Cited by 100
“INTRODUCTION Neurodegenerative diseases (NDDs) including Parkinson’s disease (PD), Alzheimer’s disease (AD), dementia with Lewy bodies, amyotrophic lateral sclerosis (ALS), and Huntington’s disease are a set of heterogeneous disorders characterized by the progressive structural and functional degradation of the nerve…”
BackgroundCellular Inclusion Bodies of Mutant Huntingtin Exon 1 Obscure Small Fibrillar Aggregate Species
Sahl, S. J., Weiss, L. E., Duim, W. C., Frydman, J., & Moerner, W. E. (2012) · Scientific Reports · doi:10.1038/srep00895 · Cited by 95
Identification of the Drosophila Ortholog of HSPB8
Carra, S., Boncoraglio, A., Kanon, B., Brunsting, J. F., Minoia, M., Rana, A., Vos, M. J., Seidel, K., Sibon, O. C. M., & Kampinga, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127498 · Cited by 102
Chernoff, N., Hill, D., Diggs, D. L., Faison, B. D., Francis, B. M., Lang, J. R., Larue, M. M., Le, T. T., Loftin, K. A., Lugo, J. N., et al. (2017) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2017.1297592 · Cited by 108
“…to be a critical factor in the formation of aberrant proteins in the CNS inmany diseases including AD, Parkinson’s disease, Huntington’s, ALS, Progressive Supranuclear Palsy (PSP), Kuru, and CreutzfeltJacob (Abdel-Salam 2014; Ashraf et al. 2014; Dobson 2001; Ellisdon and Bottomley 2004; Soto 2003).”
BackgroundModulation of Amyloid States by Molecular Chaperones
Wentink, A. S., Nussbaum-Krammer, C. I., & Bukau, B. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033969 · Cited by 97
“Althoughmany neurodegenerative conditions arise sporadically, hereditary cases link increased concentrations or aggregation propensity of signature proteins to disease severity and early onset, suggesting a causal link between protein aggregation and disease phenotypes (Soto 2003).”
BackgroundLi, M., Guan, Y., Zhao, A., Ren, J., & Qu, X. (2017) · Theranostics · doi:10.7150/thno.18459 · Cited by 90
“Misfolding, aggregation and accumulation of proteins in the brain have recently been recognized to be the common cellular and molecular mechanisms of neurodegenerative diseases including Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and prion disease…”
BackgroundAFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Ruggeri, F. S., Habchi, J., Cerreta, A., & Dietler, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518141911 · Cited by 98
“The partially folded/unfolded states of a protein, independently of its globular or naturally unfolded conformation, are vulnerable to misfolding and to aggregation into amyloid structures [4, 5, 27, 29, 44, 45].”
BackgroundRegulation of Hsf1 and the Heat Shock Response
Pincus, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_3 · Cited by 97
Pisani, L., Catto, M., Leonetti, F., Nicolotti, O., Stefanachi, A., Campagna, F., & Carotti, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797379302 · Cited by 98
“Among others, oxidative stress conditions [22], biometals imbalance [23], protein misfolding and aggregation [24], and mitochondrial damage [25] play a crucial role.”
BackgroundPaciotti, S., Bellomo, G., Gatticchi, L., & Parnetti, L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00415 · Cited by 90
Aggregation-induced emission—fluorophores and applications
Hong, Y. (2016) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/4/2/022003 · Cited by 88
“Amyloid protein fibrillation has been regarded as the pathological hallmarks for a variety of neurodegenerative diseases, diabetes and other disease conditions [51].”
BackgroundHao, C., Wang, W., Wang, S., Zhang, L., & Guo, Y. (2017) · Marine Drugs · doi:10.3390/md15040089 · Cited by 92
“In addition, the toxicity of misfolded protein aggregates is also reported to be responsible for the pathogenesis of Alzheimer’s disease [27,28].”
BackgroundRatan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 82
“As a result, processes such as abstract thought, locomotion, emotion, cognition, and memory are interrupted [2].”
BackgroundHigh-content analysis in neuroscience
Dragunow, M. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2492 · Cited by 88
“cgi?id=168600">Parkinson's disease , involve protein misfolding and aggregatio”
BackgroundAn Inducible Chaperone Adapts Proteasome Assembly to Stress
Hanssum, A., Zhong, Z., Rousseau, A., Krzyzosiak, A., Sigurdardottir, A., & Bertolotti, A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.017 · Cited by 86
“S4 cim 3- 1 W T Flag Adc17-Flag A B”
Polyglutamine diseases: a transcription disorder?
Okazawa, H. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3013-z · Cited by 98
Tea Polyphenols in Parkinson’s Disease
Caruana, M., & Vassallo, N. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_6 · Cited by 97
“ones are oxidative stress due to an increased production of reactive oxygen species (ROS), and cell toxic effects of crS protein aggregation and deposition, both finally leading to neuronal cell death by apoptosis (Soto 2003).”
BackgroundGanglioside GM1-Mediated Amyloid-beta Fibrillogenesis and Membrane Disruption
Chi, E. Y., Frey, S. L., & Lee, K. Y. C. (2007) · Biochemistry · doi:10.1021/bi062177x · Cited by 89
Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
Mukherjee, A., Morales‐Scheihing, D., Salvadores, N., Moreno‐González, I., González, C., Taylor-Presse, K., Méndez, N., Shahnawaz, M., Gaber, A. O., Sabek, O. M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161134 · Cited by 102
“Interestingly, the formation of misfolded aggregates in T2D, as well as in all other PMDs, follows a seeding/nucleation mechanism, similar to the process of prion replication, in which preformed polymers seed the aggregation of the monomeric endogenous protein (Soto et al., 2006; Soto, 2012).”
BackgroundResultInfluentialSelf-citationNatural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases
Dhahri, M., Alghrably, M., Mohammed, H. A., Badshah, S. L., Noreen, N., Mouffouk, F., Rayyan, S., Qureshi, K. A., Mahmood, D., Lachowicz, J. I., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010001 · Cited by 87
Harnessing the power of yeast to unravel the molecular basis of neurodegeneration
Tenreiro, S., Munder, M. C., Alberti, S., & Outeiro, T. F. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12271 · Cited by 88
“…of molecular events that lead to development of these neurodegenerative diseases, involves the accumulation of different misfolded protein species, ranging from oligomers to protein aggregates that accumulate intra- or extracellularly, depending on the particular disease (Soto 2003; Gorman 2008).”
BackgroundInfluentialTowards complete descriptions of the free–energy landscapes of proteins
Vendruscolo, M., & Dobson, C. M. (2004) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2004.1501 · Cited by 101
“These defence mechanisms are, however, sometimes overwhelmed, and more than 20 diseases have so far been associated with the presence of amyloid aggregates in a variety of different tissues (Soto 2003; Stefani & Dobson 2003).”
BackgroundYang, L., Wang, W., Chen, J., Wang, N., & Zheng, G. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36493 · Cited by 84
Austin, J. A., Wright, G. S. A., Watanabe, S., Grossmann, J. G., Antonyuk, S. V., Yamanaka, K., & Hasnain, S. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317317111 · Cited by 91
“of neurodegenerative-disease–causing proteins (34).”
c-Jun N-terminal Kinase Regulates Soluble Aβ Oligomers and Cognitive Impairment in AD Mouse Model
Sclip, A., Antoniou, X., Colombo, A., Camici, G. G., Pozzi, L., Cardinetti, D., Feligioni, M., Veglianese, P., Bahlmann, F. H., Cervo, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297515 · Cited by 84
Stress Signal Network between Hypoxia and ER Stress in Chronic Kidney Disease
Maekawa, H., & Inagi, R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00074 · Cited by 84
“This stress signal network might be a target for interventions aimed at ameliorating CKD. Keywords: hypoxia, er stress, chronic kidney disease, stress signal network, UPR signaling pathways”
BackgroundMorawska, M. M., Moreira, C. G., Ginde, V. R., Valko, P. O., Weiß, T., Büchele, F., Imbach, L., Masneuf, S., Kollarik, S., Prymaczok, N. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe7099 · Cited by 92
Autophagy regulation in preeclampsia: Pros and cons
Nakashima, A., Aoki, A., Kusabiraki, T., Cheng, S., Sharma, S., & Saito, S. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.08.006 · Cited by 90
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
Nakamura, T., Oh, C.-K., Zhang, X., & Lipton, S. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.002 · Cited by 88
IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases
Alberini, C. M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.03.007 · Cited by 89
Polyglutamine is Not All: The Functional Role of the AXH Domain in the Ataxin-1 Protein
de Chiara, C., Menon, R. P., Piaz, F. D., Calder, L. J., & Pastore, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.083 · Cited by 83
Liang, V., Ullrich, M., Lam, H., Chew, Y. L., Banister, S., Song, X., Zaw, T., Kassiou, M., Götz, J., & Nicholas, H. R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1558-7 · Cited by 83
“tissues vary in their capacity to respond to protein damage during aging, with neurons appearing to be particularly sensitive [72].”
BackgroundContribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau
Hudák, A., Kúsz, E., Domonkos, I., Jósvay, K., Kodamullil, A. T., Szilák, L., Hofmann‐Apitius, M., & Letoha, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-53038-z · Cited by 88
Mukherjee, A., & Soto, C. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.12.006 · Cited by 83
Self-citationOverlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 86
“One of the characteristic features of AD is amyloidogenesis (changing of soluble protein into insoluble fibrillar protein aggregates to form Aβ plaques) in various brain regions that also pathologically represent AD [46].”
BackgroundHDX-MS: An Analytical Tool to Capture Protein Motion in Action
Narang, D., Lento, C., & Wilson, D. J. (2020) · Biomedicines · doi:10.3390/biomedicines8070224 · Cited by 80
“Detailed studies of protein structure and function are critical to understanding the mechanism of biological processes and the cause of various human diseases [1,2].”
BackgroundRedox Regulation in Amyotrophic Lateral Sclerosis
Parakh, S., Spencer, D. M., Halloran, M. A., Soo, K. Y., & Atkin, J. D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/408681 · Cited by 80
“Similar to other protein disorders, the pathological hallmark of ALS is the presence of intracellular protein inclusions [48].”
ResultMaloyan, A., Gulick, J., Glabe, C. G., Kayed, R., & Robbins, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609202104 · Cited by 79
Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates
Flagmeier, P., De, S., Wirthensohn, D. C., Lee, S. F., Vincke, C., Muyldermans, S., Knowles, T. P. J., Gandhi, S., Dobson, C. M., & Klenerman, D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201700966 · Cited by 80
Protein Quality Control in Health and Disease
Dubnikov, T., Ben‐Gedalya, T., & Cohen, E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023523 · Cited by 84
“Accordingly, the presence of deposition sites that contain aggregated proteins is a neuropathological hallmark of various neurodegenerative disorders (Soto 2003).”
BackgroundKhan, Y. D., Jamil, M., Hussain, W., Rasool, N., Khan, S. A., & Chou, K. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.12.015 · Cited by 83
Ruggeri, F. S., Flagmeier, P., Kumita, J. R., Meisl, G., Chirgadze, D. Y., Bongiovanni, M. N., Knowles, T. P. J., & Dobson, C. M. (2020) · ACS Nano · doi:10.1021/acsnano.9b09676 · Cited by 81
Chapter 1 Practical Approaches to Protein Folding and Assembly
Walters, J., Milam, S. L., & Clark, A. C. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04201-8 · Cited by 78
“…are critical to function, as potential drug targets, or in determining the mechanisms for protein misfolding or aggregation (Cohen and Kelly, 2003; Soto, 2003) Outlined in this chapter is practical information for characterizing the thermodynamic and kinetic folding properties of a protein by…”
Eisele, Y. S., & Duyckaerts, C. J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1516-y · Cited by 85
“As a consequence, a normally soluble protein may become insoluble and form aggregates without any change in its amino-acid sequence [36, 114].”
Soto, P., Griffin, M. A., & Shea, J. (2007) · Biophysical Journal · doi:10.1529/biophysj.107.112086 · Cited by 82
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
Crook, Z. R., Sevilla, G. P., Friend, D., Brusniak, M.-Y., Bandaranayake, A. D., Clarke, M., Gewe, M., Mhyre, A. J., Baker, D., Strong, R. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02098-8 · Cited by 78
“(1) A simian CMV promoter59 was used instead of the standard CMV promoter.”
MethodCandelise, N., Schmitz, M., Thüne, K., Cramm, M., Rábano, A., Zafar, S., Stoops, E., Vanderstichele, H., Villar‐Piqué, A., Llorens, F., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0181-9 · Cited by 83
Kumar, S., Ravi, V. K., & Swaminathan, R. (2008) · Biochemical Journal · doi:10.1042/bj20071499 · Cited by 76
Neurotransmission systems in Parkinson’s disease
Moghaddam, H. S., Zare-Shahabadi, A., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0068 · Cited by 86
The Rules and Functions of Nucleocytoplasmic Shuttling Proteins
Fu, X., Liang, C., Li, F., Wang, L., Wu, X., Lü, A., Xiao, G., & Zhang, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051445 · Cited by 86
Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols
Shariatizi, S., Meratan, A. A., Ghasemi, A., & Nemat‐Gorgani, M. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.06.030 · Cited by 78
Endoplasmic reticulum stress impairment in the spinal dorsal horn of a neuropathic pain model
Zhang, E., Yi, M., Shin, N., Baek, H., Kim, S., Kim, E., Kwon, K., Lee, S. Y., Kim, H., Bae, Y. C., et al. (2015) · Scientific Reports · doi:10.1038/srep11555 · Cited by 80
Microcin Amyloid Fibrils A Are Reservoir of Toxic Oligomeric Species
Shahnawaz, M., & Soto, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282533 · Cited by 73
Self-citationPerrin, F. E., Boisset, G., Docquier, M., Schaad, O., Descombes, P., & Kato, A. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi357 · Cited by 84
Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo
Sowade, R. F., & Jahn, T. R. (2017) · Nature Communications · doi:10.1038/s41467-017-00579-4 · Cited by 76
Modulating Aβ33–42 Peptide Assembly by Graphene Oxide
Li, Q., Liu, L., Zhang, S., Xu, M., Wang, X., Wang, C., Besenbacher, F., & Dong, M. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201402022 · Cited by 76
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 80
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Lopes, D. M., Llewellyn, S. K., & Harrison, I. F. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00293-2 · Cited by 80
“Among the most studied proteins in this group are amyloid-β plaques in AD; tau neurofibrillary tangles in frontotemporal dementia with parkinsonism, and AD; α-synuclein Lewy bodies and neurites in PD, and dementia with Lewy bodies; huntingtin inclusions in Huntington’s disease; TDP-43 inclusions in amyotrophic lateral…”
BackgroundBranco, J., Al‐Ramahi, I., Ukani, L., Perez, A. M., Fernández-Fúnez, P., Rincón-Limas, D. E., & Botas, J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm315 · Cited by 82
Aging and the aggregating proteome
David, D. C. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00247 · Cited by 76
“The causes, consequences, and regulation of disease protein aggregation have been extensively discussed in other reviews (Soto, 2003; Ross and Poirier, 2005; Douglas and Dillin, 2010; Eisenberg and Jucker, 2012).”
BackgroundFan, Y., & He, J. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731828 · Cited by 81
“These aggregates are often cytotoxic and alter various cell signaling systems and neuron connectivity and cause neuron death through UPR and ER stress response (81, 82).”
BackgroundBeyond the Signal Sequence: Protein Routing in Health and Disease
Castro-Fernández, C., Maya‐Núñez, G., & Conn, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0010 · Cited by 76
“In contrast, the clinical symptoms and disease progression are very different among such disorders (145, 146).”
BackgroundCross Currents in Protein Misfolding Disorders: Interactions and Therapy
Morales, R., Green, K., & Soto, C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789541998 · Cited by 72
“PMDs are a group of diverse, fatal diseases resulting from the failure of a protein to fold into the correct conformation, followed by its subsequent aggregation and deposition in tissues [1,2].”
InfluentialSelf-citationPotential applications of magnetic particles to detect and treat Alzheimer's disease
Busquets, M. A., Sabaté, R., & Estelrich, J. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-538 · Cited by 72
“Although a causal relationship between amyloid deposits and the development of AD has not been conclusively demonstrated, a considerable body of experimental data suggests that amyloid aggregates are important in the etiology of AD [1-4].”
BackgroundMohamed, T., Hoang, T. A., Jelokhani‐Niaraki, M., & Rao, P. P. N. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400151a · Cited by 75
Understanding Pre‐Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint
Cheng, S., Nakashima, A., & Sharma, S. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12446 · Cited by 73
Coping with Protein Quality Control Failure
Pilla, E., Schneider, K., & Bertolotti, A. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125334 · Cited by 75
Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions
Darling, A., & Uversky, V. (2017) · Molecules · doi:10.3390/molecules22122027 · Cited by 73
Detection of protein aggregate morphology through single antifouling nanopore
Giamblanco, N., Coglitore, D., Janot, J., Coulon, P., Charlot, B., & Balme, S. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.094 · Cited by 72
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives
Bivona, G., Iemmolo, M., Agnello, L., Sasso, B. L., Gambino, C. M., Giglio, R. V., Scazzone, C., Ghersi, G., & Ciaccio, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010884 · Cited by 79
“Modified proteins like Aβ and phosphorylated Tau aggregation compromise the functionality of the autophagocytic apparatus, leading to unfolded protein response in neurons [55].”
BackgroundSong, W., Patel, A., Qureshi, H. Y., Han, D., Schipper, H. M., & Paudel, H. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06165.x · Cited by 78
“HO-1 promotes proteosomal degradation of microtubuleassociated tau protein in neuroblastoma M17 cells If HO-1 over-expression activates the ubiquitin proteosome system (UPS), other cellular substrates of the proteosome may also exhibit accelerated degradation in HO-1 over-expressing cells.”
BackgroundInfluential
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.